Can a simple blood test outsmart deadly fungal infections in blood cancer?

This study is testing whether a blood test called metagenomic next-generation sequencing (mNGS) can accurately diagnose invasive fungal disease in people with blood cancers. These patients are at high risk for such infections, which are often hard to detect and can become severe. The trial will measure how sensitive and specific the test is compared to standard methods, potentially offering a faster and more comprehensive way to identify the infection.